Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-300
Closed -$21K 713
2023
Q4
$21K Hold
300
0.01% 413
2023
Q3
$21K Hold
300
0.02% 406
2023
Q2
$24K Hold
300
0.02% 390
2023
Q1
$24K Hold
300
0.02% 364
2022
Q4
$22K Hold
300
0.02% 373
2022
Q3
$19K Hold
300
0.02% 385
2022
Q2
$21K Hold
300
0.02% 374
2022
Q1
$23K Buy
+300
New +$21.6K 0.02% 375

Other funds holding HOLX

Hazlett, Burt & Watson's HOLX Position: Q1 2024 in Review

Hazlett, Burt & Watson sold out of Hologic (HOLX) in Q1 2024, closing a stake of 300 shares — an estimated $21K sold.

Hazlett, Burt & Watson first reported a position in HOLX in Q1 2022 and held it in 8 quarters. The position peaked at $24K in Q2 2023. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2024.

  • Hazlett, Burt & Watson reported no remaining Hologic position as of Q1 2024 after selling out during the quarter.
  • Hazlett, Burt & Watson sold 300 Hologic shares in Q1 2024, an estimated $21K.
  • Hazlett, Burt & Watson first reported a position in Hologic in Q1 2022 and held it in 8 quarters.
  • Hazlett, Burt & Watson's Hologic position peaked at $24K in Q2 2023.
  • 706 funds tracked by Wall St. Rank held Hologic as of Q1 2024.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2024, filed 29 Apr 2024.